| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 4.96e-05 | 13 | 17 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 8.63e-05 | 17 | 17 | 2 | GO:0003222 | |
| GeneOntologyBiologicalProcess | venous blood vessel development | 1.20e-04 | 20 | 17 | 2 | GO:0060841 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.51e-04 | 343 | 17 | 4 | GO:0061448 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 2.39e-04 | 28 | 17 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | pericardium development | 2.39e-04 | 28 | 17 | 2 | GO:0060039 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 3.13e-04 | 32 | 17 | 2 | GO:0060561 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 3.74e-04 | 35 | 17 | 2 | GO:0003209 | |
| GeneOntologyBiologicalProcess | apoptotic nuclear changes | 4.19e-04 | 37 | 17 | 2 | GO:0030262 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 4.42e-04 | 38 | 17 | 2 | GO:0061384 | |
| GeneOntologyBiologicalProcess | cellular component disassembly involved in execution phase of apoptosis | 4.65e-04 | 39 | 17 | 2 | GO:0006921 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 5.40e-04 | 42 | 17 | 2 | GO:0003230 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 6.76e-04 | 47 | 17 | 2 | GO:1902742 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.12e-04 | 157 | 18 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.42e-04 | 201 | 18 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.74e-03 | 405 | 18 | 3 | GO:0045211 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.40e-03 | 451 | 18 | 3 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.46e-03 | 477 | 18 | 3 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 8.63e-03 | 503 | 18 | 3 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 9.60e-03 | 523 | 18 | 3 | GO:0098984 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.96e-03 | 530 | 18 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | receptor complex | 1.28e-02 | 581 | 18 | 3 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.29e-02 | 583 | 18 | 3 | GO:0097060 | |
| GeneOntologyCellularComponent | cell surface | 1.33e-02 | 1111 | 18 | 4 | GO:0009986 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.34e-02 | 591 | 18 | 3 | GO:0005911 | |
| GeneOntologyCellularComponent | adherens junction | 1.41e-02 | 212 | 18 | 2 | GO:0005912 | |
| Domain | EGF-like_Ca-bd_dom | 3.17e-06 | 124 | 16 | 4 | IPR001881 | |
| Domain | EGF | 3.38e-06 | 126 | 16 | 4 | PF00008 | |
| Domain | EGF | 3.95e-05 | 235 | 16 | 4 | SM00181 | |
| Domain | EGF_3 | 3.95e-05 | 235 | 16 | 4 | PS50026 | |
| Domain | EGF-like_dom | 4.95e-05 | 249 | 16 | 4 | IPR000742 | |
| Domain | EGF_CA | 5.05e-05 | 86 | 16 | 3 | PF07645 | |
| Domain | EGF-like_CS | 5.94e-05 | 261 | 16 | 4 | IPR013032 | |
| Domain | EGF_2 | 6.30e-05 | 265 | 16 | 4 | PS01186 | |
| Domain | EGF_CA | 7.69e-05 | 99 | 16 | 3 | PS01187 | |
| Domain | EGF_CA | 1.43e-04 | 122 | 16 | 3 | SM00179 | |
| Domain | EGF_1 | 1.23e-03 | 255 | 16 | 3 | PS00022 | |
| Domain | EGF_Ca-bd_CS | 3.06e-03 | 97 | 16 | 2 | IPR018097 | |
| Domain | ASX_HYDROXYL | 3.24e-03 | 100 | 16 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.64e-03 | 106 | 16 | 2 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 7.70e-03 | 156 | 16 | 2 | IPR009030 | |
| Pubmed | Altered cholesterol biosynthesis causes precocious neurogenesis in the developing mouse forebrain. | 9.09e-06 | 9 | 18 | 2 | 26921468 | |
| Pubmed | Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. | 3.02e-05 | 16 | 18 | 2 | 19154719 | |
| Pubmed | 3.02e-05 | 16 | 18 | 2 | 21402782 | ||
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 3.85e-05 | 18 | 18 | 2 | 36899896 | |
| Pubmed | 4.30e-05 | 19 | 18 | 2 | 22629441 | ||
| Pubmed | Isl1 Controls Patterning and Mineralization of Enamel in the Continuously Renewing Mouse Incisor. | 4.78e-05 | 20 | 18 | 2 | 28650075 | |
| Pubmed | 8.16e-05 | 26 | 18 | 2 | 14960276 | ||
| Pubmed | 1.66e-04 | 210 | 18 | 3 | 16537572 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.87e-04 | 1201 | 18 | 5 | 35696571 | |
| Interaction | EDN3 interactions | 1.76e-06 | 108 | 17 | 4 | int:EDN3 | |
| Interaction | CFC1 interactions | 3.26e-06 | 126 | 17 | 4 | int:CFC1 | |
| Interaction | ADAMTS4 interactions | 2.87e-05 | 72 | 17 | 3 | int:ADAMTS4 | |
| Interaction | ELSPBP1 interactions | 5.98e-05 | 92 | 17 | 3 | int:ELSPBP1 | |
| Interaction | PRG2 interactions | 8.06e-05 | 285 | 17 | 4 | int:PRG2 | |
| Interaction | SDF2L1 interactions | 1.29e-04 | 322 | 17 | 4 | int:SDF2L1 | |
| Interaction | NCR3 interactions | 1.32e-04 | 120 | 17 | 3 | int:NCR3 | |
| Interaction | NOTCH2NLA interactions | 2.46e-04 | 381 | 17 | 4 | int:NOTCH2NLA | |
| Interaction | FANCF interactions | 2.68e-04 | 29 | 17 | 2 | int:FANCF | |
| Interaction | WNT10A interactions | 4.38e-04 | 37 | 17 | 2 | int:WNT10A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 2.05e-03 | 172 | 18 | 2 | chr16p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 7.09e-03 | 325 | 18 | 2 | chr9q34 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 7.55e-05 | 681 | 18 | 5 | M5314 | |
| Coexpression | TOMLINS_METASTASIS_DN | 8.40e-05 | 20 | 18 | 2 | M7090 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 8.77e-05 | 703 | 18 | 5 | MM1055 | |
| Coexpression | WANG_NFKB_TARGETS | 1.22e-04 | 24 | 18 | 2 | MM1302 | |
| Coexpression | WANG_NFKB_TARGETS | 1.22e-04 | 24 | 18 | 2 | M2307 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.99e-04 | 440 | 18 | 4 | M39039 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN | 3.23e-04 | 199 | 18 | 3 | M8086 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 3.23e-04 | 199 | 18 | 3 | M6987 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.28e-04 | 200 | 18 | 3 | M291 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP | 3.28e-04 | 200 | 18 | 3 | M8051 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 3.28e-04 | 200 | 18 | 3 | M8471 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP | 3.28e-04 | 200 | 18 | 3 | M3957 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP | 3.28e-04 | 200 | 18 | 3 | M6958 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_DN | 3.43e-04 | 203 | 18 | 3 | M15912 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | 3.66e-04 | 955 | 18 | 5 | M45680 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-07 | 179 | 18 | 4 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 174 | 18 | 3 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 174 | 18 | 3 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.00e-05 | 181 | 18 | 3 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-05 | 183 | 18 | 3 | 03649492c37f9b274a1caf3e2132ce2915cf1df5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-05 | 184 | 18 | 3 | e0beb016823514eebdbfc13beb0807efb4470f08 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Early_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.42e-05 | 186 | 18 | 3 | ae4b6ecfc1850c0a01a11b9dd9718880f2a24fe0 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 187 | 18 | 3 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 187 | 18 | 3 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-05 | 188 | 18 | 3 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-05 | 188 | 18 | 3 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 191 | 18 | 3 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-05 | 192 | 18 | 3 | 2f539653a20006bef814e6b4acd1023d6fdad5c6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 192 | 18 | 3 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-05 | 193 | 18 | 3 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.05e-05 | 193 | 18 | 3 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 195 | 18 | 3 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 195 | 18 | 3 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 196 | 18 | 3 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.72e-05 | 200 | 18 | 3 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 48 | 18 | 2 | b4338a4f976425ff055a3dea48b6c1e9d6b49bac | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 48 | 18 | 2 | 551be574263b25ef971ed9ea897f44707f1f2bb7 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 48 | 18 | 2 | 1bf16774cec498d4b2b99fcdc5a7a1c3bfec24b8 | |
| ToppCell | AT1_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-04 | 90 | 18 | 2 | 6cbf30dd3992d8ccfaa74ad9781b9f8735f1ef69 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT1_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.29e-03 | 133 | 18 | 2 | b0d3ac5abd9ebd490db46a3ef2e4ae88c4bf4e34 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 136 | 18 | 2 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 137 | 18 | 2 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.38e-03 | 138 | 18 | 2 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-03 | 141 | 18 | 2 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-03 | 144 | 18 | 2 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-03 | 145 | 18 | 2 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-03 | 149 | 18 | 2 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 1.67e-03 | 152 | 18 | 2 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.78e-03 | 157 | 18 | 2 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.81e-03 | 158 | 18 | 2 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.83e-03 | 159 | 18 | 2 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-03 | 159 | 18 | 2 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-03 | 160 | 18 | 2 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-03 | 160 | 18 | 2 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 160 | 18 | 2 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-03 | 160 | 18 | 2 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.90e-03 | 162 | 18 | 2 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 163 | 18 | 2 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 163 | 18 | 2 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-03 | 163 | 18 | 2 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 163 | 18 | 2 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-03 | 163 | 18 | 2 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-03 | 164 | 18 | 2 | 4274a4f225cabf61f0fe27d8ea162b4eba612f87 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-03 | 164 | 18 | 2 | d62143450f59097ad4b34603a6257f897a769ead | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-03 | 164 | 18 | 2 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-03 | 164 | 18 | 2 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-03 | 164 | 18 | 2 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-03 | 165 | 18 | 2 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 165 | 18 | 2 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-03 | 166 | 18 | 2 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-03 | 166 | 18 | 2 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-03 | 166 | 18 | 2 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.99e-03 | 166 | 18 | 2 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-03 | 166 | 18 | 2 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-03 | 166 | 18 | 2 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-03 | 166 | 18 | 2 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-03 | 166 | 18 | 2 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 167 | 18 | 2 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.02e-03 | 167 | 18 | 2 | b89ebd4906f52b1fe6b6540ec9339284e7caddd2 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 167 | 18 | 2 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-03 | 167 | 18 | 2 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 2.02e-03 | 167 | 18 | 2 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.02e-03 | 167 | 18 | 2 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-03 | 168 | 18 | 2 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | TCGA-Pancreas|World / Sample_Type by Project: Shred V9 | 2.04e-03 | 168 | 18 | 2 | 279d5fcf9bd3f56ab560e37eed6fb3bd57dd93de | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 168 | 18 | 2 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 168 | 18 | 2 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.04e-03 | 168 | 18 | 2 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.06e-03 | 169 | 18 | 2 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.06e-03 | 169 | 18 | 2 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-03 | 169 | 18 | 2 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 170 | 18 | 2 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 170 | 18 | 2 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 171 | 18 | 2 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-03 | 171 | 18 | 2 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 172 | 18 | 2 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-03 | 172 | 18 | 2 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.14e-03 | 172 | 18 | 2 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-03 | 172 | 18 | 2 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-03 | 173 | 18 | 2 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-03 | 173 | 18 | 2 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.16e-03 | 173 | 18 | 2 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-03 | 173 | 18 | 2 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-03 | 173 | 18 | 2 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-03 | 173 | 18 | 2 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-03 | 173 | 18 | 2 | d8e965ff7e9b758876ec1521c1ccedd739e8d673 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-03 | 173 | 18 | 2 | c2d973356c40e0284fd3bd7733a164b141c66008 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-03 | 174 | 18 | 2 | fee2ee3e888ce71f9f3f05d7dc8aaa9549480205 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.18e-03 | 174 | 18 | 2 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 3.43e-07 | 195 | 18 | 5 | 4647_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.42e-05 | 194 | 18 | 4 | 5056_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.51e-05 | 197 | 18 | 4 | 5082_UP | |
| Drug | aniline mustard | 1.11e-04 | 20 | 18 | 2 | CID000011108 | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.75e-04 | 182 | 18 | 3 | 848_UP | |
| Drug | Polyphenols | 3.76e-04 | 452 | 18 | 4 | ctd:D059808 | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.94e-04 | 185 | 18 | 3 | 4327_DN | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 3.94e-04 | 185 | 18 | 3 | 944_UP | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 4.26e-04 | 190 | 18 | 3 | 2525_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.32e-04 | 191 | 18 | 3 | 5607_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 6400_DN | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 4276_UP | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 7232_DN | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 4470_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 7494_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 3604_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4234_DN | |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4092_DN | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 6285_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4227_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 5757_DN | |
| Drug | radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A | 4.66e-04 | 196 | 18 | 3 | 493_UP | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4667_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3633_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2183_DN | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4491_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3351_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 5795_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4195_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3686_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 1849_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 5435_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5349_UP | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5406_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5819_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1845_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1675_UP | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5859_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5009_UP | |
| Drug | Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5775_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3704_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3098_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6257_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3019_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5060_UP | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3818_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6863_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1181_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5801_DN | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5312_UP | |
| Drug | PI103 | 4.75e-04 | 41 | 18 | 2 | ctd:C522973 | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4023_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3003_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 1798_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 2128_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 1851_UP | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6885_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6259_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4681_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6345_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5068_UP | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6323_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 2380_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 1850_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6261_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5844_DN | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 4.87e-04 | 199 | 18 | 3 | 603_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5804_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6660_UP | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6337_DN | |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2497_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6690_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6974_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2404_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2289_UP | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 7445_UP | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5781_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 2077_UP | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 4818_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 3636_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 4797_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 6000_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 2652_DN | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 3352_UP | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 5762_UP | |
| Drug | Benzene | 5.11e-04 | 892 | 18 | 5 | ctd:D001554 | |
| Drug | norcantharidin | 5.23e-04 | 43 | 18 | 2 | CID000093004 | |
| Drug | Acetazolamide | 8.55e-04 | 55 | 18 | 2 | ctd:D000086 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPPMLPDLTLEAWP | 166 | Q99217 | |
| MLPAPAAPRWPPLLL | 1 | Q9UP79 | |
| PLWAPSLELPKPVMQ | 21 | Q9NSE2 | |
| MAPLCPSPWLPLLIP | 1 | Q16790 | |
| MWPLTVPPPLLLLLC | 1 | O95897 | |
| MPPLLAPLLCLALLP | 1 | P46531 | |
| LLWPLLLLPSAAPDP | 16 | O15232 | |
| LLLGMSLPIWLIPRP | 411 | Q9UPQ8 | |
| LARASLIMLPWPLPL | 61 | Q5U4P2 | |
| WMAPELLQLLPPDSP | 686 | Q76MJ5 | |
| MEAAPPGPPWPLLLL | 1 | O75197 | |
| IALLLWTPLPMPNPL | 81 | P03886 | |
| WTPLPMPNPLVNLNL | 86 | P03886 | |
| ASRWPPPLLLLLLPL | 6 | Q9ULI3 | |
| WLLPVLLIPKPLNPA | 6 | P62952 | |
| PPFIWTLLMPAILLL | 236 | P56937 | |
| LLWEPATPGPLPMLP | 56 | Q15572 | |
| LPMLPPLIDPWDPGL | 66 | Q15572 | |
| LLLLLQPPPPTWALS | 31 | Q9NPR2 | |
| LPELPLPSLCPLFWM | 31 | Q6UXS0 | |
| RSPPTPLLWPLLLLL | 11 | Q92692 |